Cargando…

Prior oral contraceptive use in ovarian cancer patients: assessing associations with overall and progression-free survival

BACKGROUND: Prior studies have described a reduced risk of developing ovarian cancer with the use of oral contraceptives. In this context, we decided to examine if oral contraceptive use prior to a diagnosis of ovarian cancer is associated with better overall and progression-free survival. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jatoi, Aminah, Foster, Nathan R., Kalli, Kimberly R., Vierkant, Robert A., Zhang, Zhiying, Larson, Melissa C., Fridley, Brooke, Goode, Ellen L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608126/ https://www.ncbi.nlm.nih.gov/pubmed/26471496 http://dx.doi.org/10.1186/s12885-015-1774-z

Ejemplares similares

Expression signature distinguishing two tumour transcriptome classes associated with progression-free survival among rare histological types of epithelial ovarian cancer
por: Wang, Chen, et al.
Publicado: (2016)

Integrative genomic analysis identifies epigenetic marks that mediate genetic risk for epithelial ovarian cancer
por: Koestler, Devin C, et al.
Publicado: (2014)

Genomic Analysis Using Regularized Regression in High-Grade Serous Ovarian Cancer
por: Natanzon, Yanina, et al.
Publicado: (2018)

EGFR as a prognostic biomarker and therapeutic target in ovarian cancer: evaluation of patient cohort and literature review
por: Mehner, Christine, et al.
Publicado: (2017)

Methylation of leukocyte DNA and ovarian cancer: relationships with disease status and outcome
por: Fridley, Brooke L, et al.
Publicado: (2014)

Kernel canonical correlation analysis for assessing gene–gene interactions and application to ovarian cancer
por: Larson, Nicholas B, et al.
Publicado: (2014)

Quantification of Somatic Chromosomal Rearrangements in Circulating Cell-Free DNA from Ovarian Cancers
por: Harris, Faye R., et al.
Publicado: (2016)

Risk of Ovarian Cancer and Inherited Variants in Relapse-Associated Genes
por: Peedicayil, Abraham, et al.
Publicado: (2010)

No association between a candidate TCF7L2 variant and risk of breast or ovarian cancer
por: Goode, Ellen L, et al.
Publicado: (2009)

Germline Copy Number Variation and Ovarian Cancer Survival
por: Fridley, Brooke L., et al.
Publicado: (2012)

Toward understanding the genetics of regulatory T cells in ovarian cancer
por: DeRycke, Melissa S, et al.
Publicado: (2013)

Are 5–7 Days of Folic Acid Supplementation Necessary prior to Pemetrexed? Observations from a Case Series
por: Griffin, Benjamin R., et al.
Publicado: (2013)

Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancers
por: Mehner, Christine, et al.
Publicado: (2015)

Characterization of fusion genes in common and rare epithelial ovarian cancer histologic subtypes
por: Earp, Madalene A, et al.
Publicado: (2017)

Patients’ rationale for declining participation in a cancer-associated weight loss study
por: Wanger, Tammy, et al.
Publicado: (2014)

Pemetrexed for Ovarian Cancer: A Systematic Review of the Published Literature and a Consecutive Series of Patients Treated in a Nonclinical Trial Setting
por: Egloff, Heidi, et al.
Publicado: (2014)

European American Stratification in Ovarian Cancer Case Control Data: The Utility of Genome-Wide Data for Inferring Ancestry
por: Raska, Paola, et al.
Publicado: (2012)

Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence
por: Fridley, Brooke L., et al.
Publicado: (2016)

Drug discovery using clinical outcome-based Connectivity Mapping: application to ovarian cancer
por: Raghavan, Rama, et al.
Publicado: (2016)

Polymorphisms in NF-κB Inhibitors and Risk of Epithelial Ovarian Cancer
por: White, Kristin L, et al.
Publicado: (2009)

Regular Multivitamin Supplement Use, Single Nucleotide Polymorphisms in ATIC, SHMT2, and SLC46A1, and Risk of Ovarian Carcinoma
por: Kelemen, Linda E., et al.
Publicado: (2012)

Assessment of data transformations for model-based clustering of RNA-Seq data
por: Noel-MacDonnell, Janelle R., et al.
Publicado: (2018)

Functional Folate Receptor Alpha Is Elevated in the Blood of Ovarian Cancer Patients
por: Basal, Eati, et al.
Publicado: (2009)

Advanced ovarian cancer patients identify opportunities for prehabilitation: A qualitative study
por: Polen-De, Clarissa, et al.
Publicado: (2021)

Comprehensive Cross-Population Analysis of High-Grade Serous Ovarian Cancer Supports No More Than Three Subtypes
por: Way, Gregory P., et al.
Publicado: (2016)

DNA Methylation in Ovarian Cancer Susceptibility
por: Reid, Brett M., et al.
Publicado: (2020)

Pemetrexed, Carboplatin, and Concomitant Radiation followed by Surgery for Locally Advanced Esophageal Cancer: Results of a Planned Interim Toxicity Analysis of North Central Cancer Treatment Group Study N044E
por: Katipamula, Rajini, et al.
Publicado: (2008)

Subject level clustering using a negative binomial model for small transcriptomic studies
por: Li, Qian, et al.
Publicado: (2018)

Asphyxiation with a Fentanyl Patch
por: Mansfield, Aaron S., et al.
Publicado: (2013)

Should Loss of Appetite Be Palliated in Patients with Advanced Cancer?
por: Ehret, Christopher, et al.
Publicado: (2021)

The Ratios of CD8(+) T Cells to CD4(+)CD25(+) FOXP3(+) and FOXP3(-) T Cells Correlate with Poor Clinical Outcome in Human Serous Ovarian Cancer
por: Preston, Claudia C., et al.
Publicado: (2013)

“Ultimately, mom has the call”: Viewing clinical trial decision making among patients with ovarian cancer through the lens of relational autonomy
por: Asiedu, Gladys B., et al.
Publicado: (2018)

Clinical Characteristics of Ovarian Cancer Classified by BRCA1, BRCA2, and RAD51C Status
por: Cunningham, J. M., et al.
Publicado: (2014)

Numbers Have Life: A Commentary on “Predictors of Survival in Patients with Advanced Gastrointestinal Malignancies Admitted to the Intensive Care Unit”
por: Le‐Rademacher, Jennifer G., et al.
Publicado: (2019)

Inherited Variants in Regulatory T Cell Genes and Outcome of Ovarian Cancer
por: Goode, Ellen L., et al.
Publicado: (2013)

A Latent Model for Prioritization of SNPs for Functional Studies
por: Fridley, Brooke L., et al.
Publicado: (2011)

Weight loss over time and survival: a landmark analysis of 1000+ prospectively treated and monitored lung cancer patients
por: Le‐Rademacher, Jennifer, et al.
Publicado: (2020)

Unintended Pregnancies, Their Outcome and Prior Usage of Contraception in Georgia
por: JAPARIDZE, Tamar, et al.
Publicado: (2017)

What percentage of patients with cancer develop hiccups with oxaliplatin- or cisplatin-based chemotherapy? a compilation of patient-reported outcomes
por: Ehret, Christopher, et al.
Publicado: (2023)

Assessment of published models and prognostic variables in epithelial ovarian cancer at Mayo Clinic
por: Hendrickson, Andrea Wahner, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8onuotckic9l7kmesrot1ujibc